CD96 and invasive breast carcinoma: However, the expression of CD96 in breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), lung squamous cell carcinoma (LUSC), rectum adenocarcinoma (READ), SKCM, and thyroid carcinoma (THCA) was significantly decreased.